These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38597597)

  • 21. Prognostic Value and Immune Infiltration of HPV-Related Genes in the Immune Microenvironment of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Gan Q; Mao L; Shi R; Chang L; Wang G; Cheng J; Chen R
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
    Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H
    BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
    Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F
    Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Expression of TMEM33 Predicts Poor Prognosis and Promotes Cell Proliferation in Cervical Cancer.
    Chen H; Zhao X; Li Y; Zhang S; Wang Y; Wang L; Ma W
    Front Genet; 2022; 13():908807. PubMed ID: 35832191
    [No Abstract]   [Full Text] [Related]  

  • 25. Pan-Cancer Analysis Confirms the Prognostic and Immunological Implications of the 1,25-Dihydroxy Vitamin D3 Receptor in Cervical Squamous Cell Carcinoma.
    Faris IFM; Ibrahim N; Zeanelabdeen TS; Alfaki M
    Cureus; 2024 Aug; 16(8):e66743. PubMed ID: 39268267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 27. Development and validation of an autophagy-related long non-coding RNA prognostic signature for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Zhou S; Zhang W; Cao W; Jin Q; Jiang X; Jiang X; Yang Y; Yao H; Chen G; Gao W; Zhu Y; Qi J; Tong Z
    Front Oncol; 2022; 12():1049773. PubMed ID: 36408157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma.
    Pan J; Xu L; Pan H
    Front Oncol; 2020; 10():1444. PubMed ID: 32974164
    [No Abstract]   [Full Text] [Related]  

  • 29. Metallothionein-like 5 expression is correlated with poor prognosis and promotes proliferation of cervical squamous cell carcinoma.
    Huang Y; Wu Q; Tan X
    Bioengineered; 2022 Mar; 13(3):6955-6965. PubMed ID: 35249447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SERPINB7 as a prognostic biomarker in cervical cancer: Association with immune infiltration and facilitation of the malignant phenotype.
    Wei HF; Zhang RF; Zhao YC; Tong XS
    Heliyon; 2023 Sep; 9(9):e20184. PubMed ID: 37809412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
    Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
    [No Abstract]   [Full Text] [Related]  

  • 32. Acetyl Coenzyme A Synthase 2 Acts as a Prognostic Biomarker Associated with Immune Infiltration in Cervical Squamous Cell Carcinoma.
    Li CJ; Chiu YH; Chang C; Chang YI; Sheu JJ; Chiang AJ
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34206705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of EPHX2 and RMI2 as two novel key genes in cervical squamous cell carcinoma by an integrated bioinformatic analysis.
    Liu J; Nie S; Gao M; Jiang Y; Wan Y; Ma X; Zhou S; Cheng W
    J Cell Physiol; 2019 Nov; 234(11):21260-21273. PubMed ID: 31041817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Stemness-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma by Integrated Bioinformatics Analysis.
    Guo H; Wang S; Ju M; Yan P; Sun W; Li Z; Wu S; Lin R; Xian S; Yang D; Wang J; Huang Z
    Front Cell Dev Biol; 2021; 9():642724. PubMed ID: 33842467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Signatures Based on Ferroptosis- and Immune-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Xing C; Yin H; Yao ZY; Xing XL
    Front Oncol; 2021; 11():774558. PubMed ID: 35087751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC).
    Gong M; Shen F; Li Y; Ming L; Hong L
    PLoS One; 2023; 18(8):e0290462. PubMed ID: 37594950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of SRPK1 (serine/arginine-rich protein-specific kinase 1) is associated with progression and unfavorable prognosis in cervical squamous cell carcinoma.
    Dong Z; Chang X; Xie L; Wang Y; Hou Y
    Bioengineered; 2022 Mar; 13(3):6100-6112. PubMed ID: 35192432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of
    Zhao S; Yu M
    DNA Cell Biol; 2020 Feb; 39(2):255-272. PubMed ID: 31977248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elucidating prognosis in cervical squamous cell carcinoma and endocervical adenocarcinoma: a novel anoikis-related gene signature model.
    Wang M; Ying Q; Ding R; Xing Y; Wang J; Pan Y; Pan B; Xiang G; Liu Z
    Front Oncol; 2024; 14():1352638. PubMed ID: 38988712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unraveling the role of the circadian clock genes in cervical squamous cell carcinoma and endocervical adenocarcinoma: A prognostic indicator for prognostic, immunotherapy response, and chemotherapy sensitivity.
    Xu J; Huang X; Gou S; Luo H; Zeng S; Zhang Q; Wu Q; Chi H; Yang G
    J Cancer; 2024; 15(9):2788-2804. PubMed ID: 38577592
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.